Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Fluorescence Imaging in TGCT Surgery
NCT07315841Phase 4Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indocyanine green in tenosynovial giant cell tumor (TGCT), sponsored by Shanghai Sixth People's Hospital. Started Jan 2026; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
tenosynovial giant cell tumor (TGCT)
Beyond the preview
Go deeper on NCT07315841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07315841.